Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
---|
10/23/2003 | WO2003007954A3 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors |
10/23/2003 | WO2002046128A3 Quaternary amino acids on solid supports |
10/23/2003 | US20030199698 Anticoagulants such as 2'-tert-butylaminosulfonylbiphenyl-4-yl-(3-(5-methyl-1,2,4-oxadiazol-3 -yl)benzyl)(2-cyanoethyl) carbamate, used for prophylaxis of cardiovascular disorders |
10/23/2003 | US20030199560 Bisaryl compound and medicament for cancer treatment comprising the same |
10/23/2003 | US20030199559 Process for making amlodipine maleate |
10/23/2003 | US20030199552 Amide derivatives as NMDA receptor antagonists |
10/23/2003 | US20030199550 Cyclohexane derivatives containing amine or amine oxide, useful for treating hypercholesterolemia and hyperlipemia |
10/23/2003 | US20030199549 Novel piperidine based MCH antagonists for treatment of obesity and CNS disorders |
10/23/2003 | US20030199548 Administering quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives containing one of the ring selected from benzene, pyridine, thienyl, furanyl, imidazolyl and triazolyl for therapy in pain management |
10/23/2003 | US20030199540 Fluoroalkyoxybenzylamino derivatives of nitrogen containing heterocycles |
10/23/2003 | CA2482341A1 Novel methoxybenzamide compounds for use in mch receptor related disorders |
10/23/2003 | CA2480832A1 Nitric oxide donors, compositions and methods of use |
10/22/2003 | EP1354868A1 Perfluoronated cycle-containing tertiary amines used as a basis for gas-conveying emulsions and device for the production thereof |
10/22/2003 | EP1354587A1 Medicinal compositions for oral use |
10/22/2003 | EP1353906A1 Process for the preparation of (3-cyano-1h-indol-7-yl)(4-(4-fluorophenethyl)piperazin-1-yl)-methanone and salts thereof |
10/22/2003 | EP1353905A2 Piperidine/piperazine-type inhibitors of p38 kinase |
10/22/2003 | EP1353898A2 Compounds to treat alzheimer's disease |
10/22/2003 | EP1353888A1 A recovery method |
10/22/2003 | EP1353750A1 Stable free nitroxyl radicals as oxidation catalysts and process for oxidation |
10/22/2003 | EP1353662A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
10/22/2003 | EP0976702B1 Method for inhibiting polymerization of a vinyl compound |
10/22/2003 | EP0927184B1 3-substituted pyrido 4',3':4,5]thieno 2,3-d]pyrimidine derivatives, their preparation and their use |
10/22/2003 | EP0892802B1 Spiro(cyclopent(b)indole-piperidines) and n-phenyl-hydrazon intermediates for their preparation, both being acetylcholinesterase and mao inhibitors |
10/22/2003 | CN1451065A Chlorohydrin and cationic compounds having high affinity for pulp paper |
10/22/2003 | CN1450992A Piperazine derivatives used as CCR5 antagonists |
10/22/2003 | CN1450898A Compounds for treating fibromyalgia and chronic fatigue syndrome |
10/22/2003 | CN1450894A Phenylethylamines and condensed rings variants as prodrugs of catecholamines and their use |
10/22/2003 | CN1125053C Method of preparing norbenzomorphane as an intermediate in the preparation of pharmaceutically useful benzomorphane derivatives in particular |
10/22/2003 | CN1125046C Butadiene derivatives and process for preparing thereof |
10/22/2003 | CN1125044C Novel prostaglandin synthase inhibitors |
10/21/2003 | US6635764 Urea compounds that are muscarinic receptor antagonists and agonists, administering to the mammal the urea compound to treat urinary incontinence, chronic pulmonary obstructive disease, asthma, hyper salivation, blurred vision etc. |
10/21/2003 | US6635661 Heterocyclic analgesic compounds and methods of use thereof |
10/21/2003 | US6635658 Amino-tetralin derivatives as muscarinic receptor antagonists |
10/21/2003 | US6635643 For treating conditions which are related to impairment of gastric emptying |
10/21/2003 | US6635630 Respiratory system disorders; antiinflammatory agents |
10/21/2003 | US6635284 Delivery of multiple doses of medications |
10/21/2003 | US6635270 NMDA receptor agonist pharmaceutical compositions |
10/16/2003 | WO2003084943A2 Terphenyl derivatives, preparation thereof, compositions containing same |
10/16/2003 | WO2003084941A2 Hydroxamic acid derivatives |
10/16/2003 | WO2003084929A1 Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa |
10/16/2003 | WO2003084928A1 Alpha, omega-dicarboximide derivatives as useful uro-selective α1α adrenoceptor blockers |
10/16/2003 | WO2003084927A1 Haloalkenes, process for production thereof, and pest controllers containing the same |
10/16/2003 | WO2003084917A1 (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives |
10/16/2003 | WO2003084916A2 Compounds that modulate ppar activity and methods for their preparation |
10/16/2003 | WO2003084540A2 Compositions comprising mmp7 modulators for the treatment of chronic pain |
10/16/2003 | WO2003084533A1 N-`4-(2-imino-pyrrolidin-1-yl)phenyl!-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases |
10/16/2003 | WO2003037271A3 Compounds, pharmaceutical compositions and methods of use therefor |
10/16/2003 | WO2003022218A3 Carboxylate-gated-nitroxide (cgn) compounds and compositions and methods of use thereof |
10/16/2003 | WO2003016274A3 2-substituted piperidines that are ligands for monoamine receptors and transporters |
10/16/2003 | WO2002100849A3 Novel nitriles useful as reversible inhibitors of cysteine proteases |
10/16/2003 | WO2002076939A3 Cysteine protease inhibitors |
10/16/2003 | US20030195356 4-Aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) piperidines tetrahydropyridines or piperazines |
10/16/2003 | US20030195229 Administering viricides such as N-nonenyl glucosamine, and optionally with mixtures of nucleosides, nucleotides, immunomodulators or immunostimulants for prophylaxis viral diseases |
10/16/2003 | US20030195227 Retroviral protease inhibitors |
10/16/2003 | US20030195223 Antithrombotic agents |
10/16/2003 | US20030195191 N-sulfonyl hydroxamic acid derivatives as inhibitors of cd23 |
10/16/2003 | US20030195190 For therapy of allergic rhinitis, ulcer or anorexia, diabetes, Alzheimer's disease, narcolepsy or attention deficit disorder |
10/16/2003 | US20030192132 (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds |
10/16/2003 | CA2481888A1 Alpha, omega-dicarboximide derivatives as useful uro-selective a1a adrenoceptor blockers |
10/16/2003 | CA2481879A1 Hydroxamic acid derivatives |
10/16/2003 | CA2481392A1 Terphenyl derivatives, preparation thereof, compositions containing same |
10/16/2003 | CA2481035A1 (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives |
10/16/2003 | CA2481026A1 N-`4-(2-imino-pyrrolidin-1-yl)phenyl!-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases |
10/16/2003 | CA2478340A1 Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa |
10/15/2003 | EP1351959A1 Novel pleuromutilin derivatives |
10/15/2003 | EP1351946A2 Materials and methods to potentiate cancer treatment |
10/15/2003 | EP1351938A1 Phenyl derivatives |
10/15/2003 | EP1351937A1 Aryl piperidine derivatives as inducers of ldl-receptor expression |
10/15/2003 | EP1351936A1 Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression |
10/15/2003 | EP1351935A1 Aryl piperidine derivatives as inducers of ldl-receptor expression |
10/15/2003 | EP1351933A1 Il-8 receptor antagonists |
10/15/2003 | EP1351928A2 Novel n(phenylsulphonyl)glycine derivatives and their therapeutic use |
10/15/2003 | EP1351921A1 Novel 1,4-diamino-2-alkenyl-benzene derivatives and colorants containing said compounds |
10/15/2003 | EP1135370B1 Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds |
10/15/2003 | CN1449493A Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
10/15/2003 | CN1449382A Polyarylcarboxamides useful as lipid lowering agents |
10/15/2003 | CN1449373A Process for producing methacryloyl reaction product |
10/15/2003 | CN1124270C Cyclopentene derivatives useful as antagonists of the motilin receptor |
10/15/2003 | CN1124260C Para retinoic acid |
10/15/2003 | CN1124258C Substituted dihydropyridine dicarboxylic ester |
10/14/2003 | US6632963 Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
10/14/2003 | US6632895 Functionalized alkoxyamine initiators |
10/14/2003 | US6632827 Compositions of optically pure (+) norcisapride |
10/14/2003 | CA2291994C Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents |
10/14/2003 | CA2122911C 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents |
10/09/2003 | WO2003082842A1 Piperazinyl- or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase |
10/09/2003 | WO2003082828A1 Substituted tetrahydroisoquinolines as c5a receptor modulators |
10/09/2003 | WO2003082820A1 (1-indanone)-(1,2,3,6-tetrahydropyridine) derivative |
10/09/2003 | WO2003082819A1 N-phenyl-n-(4-piperidinyl)amide derivative |
10/09/2003 | WO2003082818A1 Alkaloids compounds, analgesic pharmaceuticals and their preparation |
10/09/2003 | WO2003082808A1 Benzamide derivatives |
10/09/2003 | WO2003082268A2 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
10/09/2003 | WO2003082260A2 Tuberculosis treatment using pleuromutilin derivatives |
10/09/2003 | WO2003082205A2 Compounds and methods |
10/09/2003 | WO2003082190A2 Spirocyclic amides as cannabinoid receptor modulators |
10/09/2003 | WO2003045917A3 Ccr-3 receptor antagonists vii |
10/09/2003 | WO2002009686A3 Cdc25 phosphatase inhibitors |
10/09/2003 | US20030191319 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
10/09/2003 | US20030191317 Sulfonyl aryl or heteroaryl hydroxamic acid compounds |
10/09/2003 | US20030191316 A 2-fluorocycloalkyl-2-hydroxy-2-phenyl-ethanoyl)oxy amine salt derivatives; antagonist for treating diseases associated with muscarine M3 receptors, respiratory system disorders; side effect reduction, use as inhalants |